Macular pigment, visual function, and macular disease among subjects with Alzheimer's disease: an exploratory study.

BACKGROUND The macula (central retina) contains a yellow pigment, comprising the dietary carotenoids lutein (L), zeaxanthin (Z), and meso-zeaxanthin, known as macular pigment (MP). The concentrations of MP's constituent carotenoids in retina and brain tissue correlate, and there is a biologically-plausible rationale, supported by emerging evidence, that MP's constituent carotenoids are also important for cognitive function. OBJECTIVE To investigate if patients with Alzheimer's disease (AD) are comparable to controls in terms of MP and visual function. METHODS 36 patients with moderate AD and 33 controls with the same age range participated. MP was measured using dual-wavelength autofluorescence (Heidelberg Spectralis®); cognitive function was assessed using a battery of cognition tests (including Cambridge Neuropsychological Test Automated Battery). Visual function was recorded by measuring best corrected visual acuity (BCVA) and contrast sensitivity (CS). Serum L and Z concentrations (by HPLC) and age-related macular degeneration (AMD, by retinal examination) status were also assessed. RESULTS In the AD group, central MP (i.e., at 0.23°) and MP volume were significantly lower than the control group (p < 0.001 for both), as were measures of BCVA, CS, and serum L and Z concentrations (p < 0.05, for all). CONCLUSION AD patients were observed to exhibit significantly less MP, lower serum concentrations of L and Z, poorer vision, and a higher occurrence of AMD when compared to control subjects. A clinical trial in AD patients designed to investigate the impact of macular carotenoid supplementation with respect to MP, visual function, and cognitive function is merited.

[1]  F. Khachik,et al.  Separation, identification, and quantification of carotenoids in fruits, vegetables and human plasma by high performance liquid chromatography , 1991 .

[2]  T. Robbins,et al.  A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. , 1988, Brain : a journal of neurology.

[3]  A. Hofman,et al.  Is age-related maculopathy associated with Alzheimer's Disease? The Rotterdam Study. , 1999, American journal of epidemiology.

[4]  S. Kritchevsky,et al.  Macular pigment optical density is related to cognitive function in older people. , 2014, Age and ageing.

[5]  T. Clemons,et al.  Cognitive impairment in the Age-Related Eye Disease Study: AREDS report no. 16. , 2006, Archives of ophthalmology.

[6]  S. Booth,et al.  Human plasma carotenoid response to the ingestion of controlled diets high in fruits and vegetables. , 1996, The American journal of clinical nutrition.

[7]  S. Beatty,et al.  Low macular pigment optical density is associated with lower cognitive performance in a large, population-based sample of older adults , 2013, Neurobiology of Aging.

[8]  Gail Clement,et al.  A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB. , 2009, Human molecular genetics.

[9]  F. Khachik,et al.  Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. , 1997, Investigative ophthalmology & visual science.

[10]  V. Janout,et al.  Epidemiological of and risk factors for Alzheimer's disease: a review. , 2012, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[11]  T. Robbins,et al.  Planning and spatial working memory following frontal lobe lesions in man , 1990, Neuropsychologia.

[12]  S. Beatty,et al.  Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration , 2012, British Journal of Nutrition.

[13]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[14]  S. Beatty,et al.  Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment. , 2012, Experimental eye research.

[15]  William J Feuer,et al.  Impact of visual function on computer task accuracy and reaction time in a cohort of patients with age-related macular degeneration. , 2002, American journal of ophthalmology.

[16]  H. Soininen,et al.  Age-related macular degeneration (AMD): Alzheimer's disease in the eye? , 2011, Journal of Alzheimer's disease : JAD.

[17]  D. Snodderly,et al.  Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women , 2008, Nutritional neuroscience.

[18]  D. Snodderly,et al.  Macular lutein and zeaxanthin are related to brain lutein and zeaxanthin in primates , 2013, Nutritional neuroscience.

[19]  C. Qiu.  Preventing Alzheimer's disease by targeting vascular risk factors: hope and gap. , 2012, Journal of Alzheimer's disease : JAD.

[20]  Cynthia A. Toth,et al.  Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. , 2013, JAMA.

[21]  K. Ohno-Matsui.  Parallel findings in age-related macular degeneration and Alzheimer’s disease , 2011, Progress in Retinal and Eye Research.

[22]  M. Mathews-Roth,et al.  Beta-carotene content of certain organs from two patients receiving high doses of beta-carotene. , 1976, Clinical chemistry.

[23]  S. Beatty,et al.  A review of the evidence germane to the putative protective role of the macular carotenoids for age-related macular degeneration. , 2012, Molecular nutrition & food research.

[24]  Billy R Wooten,et al.  CFF thresholds: relation to macular pigment optical density , 2005, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[25]  S. Beatty,et al.  Psychophysical impact and optical and morphological characteristics of symptomatic non-advanced cataract , 2011, Eye.

[26]  P. Aisen,et al.  Inflammatory processes and Alzheimer’s disease , 2004, Expert review of neurotherapeutics.

[27]  D. Harman.  Free radical theory of aging. , 2003, Mutation research.

[28]  P T de Jong,et al.  An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .

[29]  D M Snodderly,et al.  A practical method for measuring macular pigment optical density. , 1999, Investigative ophthalmology & visual science.

[30]  Jim Stack,et al.  Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. , 2007, Experimental eye research.

[31]  S. Beatty,et al.  Concordance of macular pigment measurements obtained using customized heterochromatic flicker photometry, dual-wavelength autofluorescence, and single-wavelength reflectance. , 2013, Experimental eye research.

[32]  J. M. Rusted,et al.  The effects of scopolamine on working memory in healthy young volunteers , 2004, Psychopharmacology.

[33]  N. Craft,et al.  Carotenoid, tocopherol, and retinol concentrations in elderly human brain. , 2004, The journal of nutrition, health & aging.

[34]  Robert F Mullins,et al.  A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.

[35]  K. Blennow,et al.  Association of complement factor H Y402H gene polymorphism with Alzheimer's disease , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[36]  S. Beatty,et al.  The impact of macular pigment augmentation on visual performance using different carotenoid formulations. , 2012, Investigative ophthalmology & visual science.

[37]  S. Beatty,et al.  Measurement of Macular Pigment Optical Density Using Two Different Heterochromatic Flicker Photometers , 2007, Current eye research.

[38]  A. Blackwell,et al.  Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline , 2010, Alzheimer's & Dementia.

[39]  F. Eperjesi,et al.  A randomised controlled trial investigating the effect of lutein and antioxidant dietary supplementation on visual function in healthy eyes. , 2008, Clinical nutrition.

[40]  G. Perry,et al.  Oxidative stress in Alzheimer disease: A possibility for prevention , 2010, Neuropharmacology.

[41]  Elizabeth J Johnson.  A possible role for lutein and zeaxanthin in cognitive function in the elderly. , 2012, The American journal of clinical nutrition.

[42]  J. Min,et al.  Serum Lycopene, Lutein and Zeaxanthin, and the Risk of Alzheimer's Disease Mortality in Older Adults , 2013, Dementia and Geriatric Cognitive Disorders.

[43]  François C Delori,et al.  Autofluorescence method to measure macular pigment optical densities fluorometry and autofluorescence imaging. , 2004, Archives of biochemistry and biophysics.

[44]  D. Musch.  Evidence for including lutein and zeaxanthin in oral supplements for age-related macular degeneration. , 2014, JAMA ophthalmology.

[45]  S A Burns,et al.  Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. , 2001, Journal of the Optical Society of America. A, Optics, image science, and vision.

[46]  Usha Chakravarthy,et al.  Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration. , 2013, Ophthalmology.

[47]  P. Mecocci,et al.  Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease , 2003, Neurobiology of Aging.

[48]  M. Boulton,et al.  The role of oxidative stress in the pathogenesis of age-related macular degeneration. , 2000, Survey of ophthalmology.

[49]  P. Rabbitt,et al.  Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. , 1994, Dementia.

[50]  K. Nishida,et al.  Effect of 1-year lutein supplementation on macular pigment optical density and visual function , 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.

[51]  Robert C. Green,et al.  Relationship between Serum and Brain Carotenoids, α-Tocopherol, and Retinol Concentrations and Cognitive Performance in the Oldest Old from the Georgia Centenarian Study , 2013, Journal of aging research.

[52]  T. Strandberg.  Alzheimer's disease and angiogenesis , 2003, The Lancet.

[53]  S. Kritchevsky,et al.  The relation between serum xanthophylls, fatty acids, macular pigment and cognitive function in the Health ABC Study , 2008 .

[54]  Paul V Garcia,et al.  Macular pigment and visual performance in glare: benefits for photostress recovery, disability glare, and visual discomfort. , 2011, Investigative ophthalmology & visual science.

[55]  J. Quinn,et al.  Nutritional biomarkers in Alzheimer's disease: the association between carotenoids, n-3 fatty acids, and dementia severity. , 2008, Journal of Alzheimer's disease : JAD.

[56]  F. Khachik,et al.  Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. , 2001, Experimental eye research.

[57]  A. Ramé.  [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.

[58]  Michelle K. Lupton,et al.  Alzheimer's disease and age-related macular degeneration have different genetic models for complement gene variation , 2012, Neurobiology of Aging.

[59]  R. Bone,et al.  Analysis of the macular pigment by HPLC: retinal distribution and age study. , 1988, Investigative ophthalmology & visual science.